Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Total Neoadjuvant Treatment Versus Conventional Neo-chemoradiotherapy in Locally Advanced Rectal Cancer With High Risk Factors: a Multicenter Randomized Phase III Clinical Study.

NCT03177382 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT03177382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03177382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Total Neoadjuvant Treatment Versus Conventional Neo-chemoradiotherapy in Locally Advanced Rectal Cancer With High Risk Factors: a Multicenter Randomized Phase III Clinical Study.
Lead sponsor
West China Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
June 15, 2017
Completion date
May 30, 2023
Enrollment
458 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chemoradiotherapy, high risk factors, local advanced rectal cancer, total neoadjuvant treatment